Suppr超能文献

可溶性因子CD14、CD163和迁移抑制因子与子宫内膜异位症相关不孕症有关。

Soluble Factors CD14, CD163, and Migration Inhibitory Factor Are Associated with Endometriosis-Related Infertility.

作者信息

Rahmawati Nanda Yuli, Ahsan Fadhil, Santoso Budi, Mufid Alfin Firasy, Sa'adi Ashon, Dwiningsih Sri Ratna, Tunjungseto Arif, Widyanugraha M Y Ardianta

机构信息

Doctoral Program of Medical Science, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.

Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.

出版信息

Gynecol Obstet Invest. 2024;89(4):335-345. doi: 10.1159/000538525. Epub 2024 Apr 3.

Abstract

OBJECTIVES

Myeloid cell-derived factors contribute to the immunopathology of endometriosis. Soluble CD14 (sCD14), CD163 (sCD163), and MIF serve as in vivo markers of myeloid function. However, these soluble molecules are largely unexplored in women with endometriosis-related infertility cases. We investigated three soluble markers, namely sCD14, sCD163, and MIF, in cases of infertility associated with endometriosis and correlated its level to the stage of endometriosis.

DESIGN

Eighty-seven women newly diagnosed with endometriosis or other benign gynecologic control cases linked to infertility were prospectively recruited and underwent diagnostic laparoscopy.

PARTICIPANTS

Forty-four patients with endometriosis were included in this study, comprising 19 patients with early-endometriosis (stages I and II) and 25 late-endometriosis (stages III and IV) based on the revised American Society for Reproductive Medicine (rASRM) classification. The remaining 43 patients constituted a control group with infertility due to other causes.

METHODS

The levels of sCD14, sCD163, and MIF in serum and peritoneal fluid were assessed using ELISA.

RESULTS

Endometriosis women exhibited significantly higher serum levels of sCD163 and MIF levels compared to the control group. Both sCD163 and MIF levels displayed a positive correlation with the rASRM adhesion score. Moreover, the MIF level in serum had a positive correlation with the rASRM endometriosis score. In receiver operating characteristic analysis, serum sCD163 and MIF could significantly discriminate endometriosis and non-endometriosis in infertility cases.

LIMITATIONS

Some limitations of the current study deserve to be underlined. First, the sensitive ELISA method was the sole-validated tool for detecting the markers in patient samples. Second, healthy or fertile women were not involved as the control group.

CONCLUSIONS

The elevated systemic levels of sCD163 and MIF correlated with the severity of endometriosis. These soluble molecules have a potential diagnostic capacity as a non-invasive biomarker. Furthermore, our data warrants future studies on the underlying mechanism of sCD163 and MIF in endometriosis-related infertility.

摘要

目的

髓样细胞衍生因子参与子宫内膜异位症的免疫病理过程。可溶性CD14(sCD14)、CD163(sCD163)和巨噬细胞移动抑制因子(MIF)可作为髓样细胞功能的体内标志物。然而,在子宫内膜异位症相关不孕症患者中,这些可溶性分子在很大程度上尚未得到充分研究。我们研究了sCD14、sCD163和MIF这三种可溶性标志物在子宫内膜异位症相关不孕症患者中的情况,并将其水平与子宫内膜异位症的分期相关联。

设计

前瞻性招募87名新诊断为子宫内膜异位症或与不孕症相关的其他良性妇科对照病例的女性,并进行诊断性腹腔镜检查。

参与者

本研究纳入44例子宫内膜异位症患者,根据美国生殖医学学会修订版(rASRM)分类,其中19例为早期子宫内膜异位症(I期和II期),25例为晚期子宫内膜异位症(III期和IV期)。其余43例患者构成因其他原因导致不孕的对照组。

方法

采用酶联免疫吸附测定(ELISA)法评估血清和腹腔液中sCD14、sCD163和MIF的水平。

结果

与对照组相比,子宫内膜异位症患者血清中sCD163和MIF水平显著升高。sCD163和MIF水平均与rASRM粘连评分呈正相关。此外,血清中MIF水平与rASRM子宫内膜异位症评分呈正相关。在受试者工作特征分析中,血清sCD163和MIF可显著区分不孕症患者中的子宫内膜异位症和非子宫内膜异位症。

局限性

本研究的一些局限性值得强调。首先,灵敏的ELISA法是检测患者样本中标志物的唯一经过验证的工具。其次,未纳入健康或有生育能力的女性作为对照组。

结论

sCD163和MIF的全身水平升高与子宫内膜异位症的严重程度相关。这些可溶性分子具有作为非侵入性生物标志物的潜在诊断能力。此外,我们的数据为未来研究sCD163和MIF在子宫内膜异位症相关不孕症中的潜在机制提供了依据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验